Details

DSEN Abstract: SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Apr 20, 2026 · edition #8
Timestamp
2026-04-20T04:37:37.375Z
Language
en
ID
1491281
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview